Abdul Latif
- Pharmacology top 2%
- Cholinesterase and Neurodegenerative Diseases 11
- Plant-based Medicinal Research 6
- Organic Chemistry top 5%
- Synthesis and biological activity 22
- Synthesis and Characterization of Heterocyclic Compounds 7
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases 11
- Plant-based Medicinal Research 6
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities 9
-
- Natural Antidiabetic Agents Studies 8
-
- Computational Drug Discovery Methods 7
-
- Enzyme function and inhibition 5
- Co-authors
- Mumtaz AliTajuddin TajuddinManzoor AhmadShamshad AhmadAhmed Al‐HarrasiAjmal KhanAbdur RaufAftab Alam
- Journals
- SHILAP Revista de lepidopterología (1 paper)Phytochemistry (1 paper)RSC Advances (3 papers)
In The Last Decade
Abdul Latif
85 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 120
- Pharmacology 242
- Complementary and alternative medicine 197
- Organic Chemistry 565
- Pharmacology 302
- Biochemistry 93
Countries citing papers authored by Abdul Latif
This map shows the geographic impact of Abdul Latif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul Latif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul Latif more than expected).
Fields of papers citing papers by Abdul Latif
This network shows the impact of papers produced by Abdul Latif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul Latif. The network helps show where Abdul Latif may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abdul Latif, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 12 | |
| 5 | 2024 | 18 | |
| 6 | 2024 | 11 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 29 | |
| 12 | 2023 | 40 | |
| 13 | 2022 | 74 | |
| 14 | 2022 | 52 | |
| 15 | 2018 | 16 | |
| 16 | Physico-chemical and phytochemical standardization of Itrifal Ustukhuddus: a pharmacopoeial Unani compound formulation. | 2015 | 1 |
| 17 | Evaluation of extracts of seeds of Syzygium cumini L. for hepatoprotective activity using CCl4-induced stressed rats. | 2015 | 8 |
| 18 | A New Antioxidant Triterpenoid from the Stem Wood of Sorbus lanata | 2014 | 2 |
| 19 | Pharmacologically active C-19 diterpenoid alkaloids from the aerial parts of Aconitum laeve Royle. | 2014 | 9 |
| 20 | Scientific validation of Unani compound formulation for its efficacy in bronchial asthma | 2009 | 3 |
About Abdul Latif
Abdul Latif is a scholar working on Drug Discovery, Pharmacology and Biochemistry, having authored 97 papers that have together received 1.7k indexed citations. Recurring topics across this work include Synthesis and biological activity (22 papers), Cholinesterase and Neurodegenerative Diseases (11 papers), Phytochemicals and Antioxidant Activities (9 papers), Natural Antidiabetic Agents Studies (8 papers), Computational Drug Discovery Methods (7 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers), Plant-based Medicinal Research (6 papers) and Enzyme function and inhibition (5 papers). The work is most often cited by research in Pharmacology (242 citations), Complementary and alternative medicine (197 citations) and Organic Chemistry (565 citations). Abdul Latif has collaborated with scholars based in Pakistan, Oman and China. Frequent co-authors include Mumtaz Ali, Tajuddin Tajuddin, Manzoor Ahmad, Shamshad Ahmad, Ahmed Al‐Harrasi, Ajmal Khan, Abdur Rauf, Aftab Alam, Nadeem Siddiqui and Zainab Zainab. Their work appears in journals such as SHILAP Revista de lepidopterología, Phytochemistry and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.